L'archivio delle pubblicazioni di Fondazione ICONA

2017

J Ghosn, T Bayan, K Meixenberger, L Tran, P Frange, A d’Arminio Monforte, R Zangerle, C de Mendoza, E Krastinova, K Porter, L Meyer and ML Chaix on behalf of the CASCADE Collaboration in EuroCoord. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus. J Antimicrob Chemother; doi:10.1093/jac/dkx247

2014

N Pantazis, K Porter, D Costagliola, A De Luca, J Ghosn, M Guiguet, A Johnson, A Kelleher, C Morrison, R Thiebaut, L Wittkop, G Touloumi, for the CASCADE Collaboration in EuroCoord. Temporal trends in prognostic markers of HIV-1 virulence and transmissibility. An observational cohort study. Lancet HIV 2014; doi:10.1016/S2352-3018(14)00002-2
J van der Helm, R Geskus, S Lodi, L Meyer, H Schuitemaker, B Gunsenheimer-Bartmeyer, A d'Arminio Monforte, A Olson, G Touloumi, C Sabin, K Porter, M Prins, on behalf of CASCADE Collaboration in EuroCoord. Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study. September 19, 2014

2013

S Lodi, M Fisher, A Phillips, A De Luca, J Ghosn, R Malyuta, R Zangerle, S Moreno, P Vanhems, F Boufassa, M Guiguet, K Porter, for CASCADE Collaboration in EuroCoord. Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection. PLoS ONE 2013;8:e78642
G Touloumi, N Pantazis, ML Chaix, HC Bucher, R Zangerle, AM Kran, R Thiebaut, B Masquelier, C Kucherer, A d'Arminio Monforte, L Meyer, K Porter; for CASCADE Collaboration in EuroCoord. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration. PLoS One. 2013 Jul 30;8(7):e71174.
Y Madec, F Boufassa, K Porter, M Prins, C Sabin, A d'Arminio Monforte, P Amornkul, B Bartmeyer, M Sannes, A Venet, O Lambotte, L Meyer; on behalf of the CASCADE Collaboration in Eurocoord. Natural history of HIV-control since seroconversion. AIDS. 2013 Aug 1. [Epub ahead of print]
S Lodi, J del Amo, A d'Arminio Monforte, S Abgrall, C Sabin, C Morrison, H Furrer, R Muga, K Porter, E Girardi; CASCADE collaboration in EuroCoord. Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax. 2013 Mar;68(3):207-13.

2012

I Jarrin, N Pantazis, MJ Gill, R Geskus, S Perez-Hoyos, L Meyer, M Prins, G Touloumi, A Johnson, O Hamouda, PG de Olalla, K Porter, J del Amo; CASCADE Collaboration in EuroCoord. Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. Clin Infect Dis. 2012 Jan 1;54(1):111-8.

2011

C Mussini, A Cossarizza, C Sabin, A Babiker, A De Luca, A Heiner, C Bucher, M Fisher, G Rezza, K Porter, M Dorrucci. Decline of CD4+ T cell count before start of therapy and immunological response to treatment in antiretroviral-naïve individuals. AIDS 2011; 15;25:1041-1049
H Jaffe, B De Stavola, L Carpenter, K Porter and D Cox. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS 2011; 25:1395-1403
L Wittkop, H Günthard, F de Wolf, D Dunn, A Cozzi-Lepri, A de Luca, C Kücherer, N Obel, V von Wyl, B Masquelier, C Stephan, C Torti, A Antinori, F García, A Judd, K Porter, R Thiébaut, H Castro, AL van Sighem, C Colin, J Kjaer, JD Lundgren, R Paredes, A Pozniak, B Clotet, A Phillips, D Pillay, G Chêne, for the EuroCoord-CHAIN study group. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011;11:363-371

Publications